Thermo Fisher’s €10.7bn quote to purchase Qiagen has collapsed after the Dutch diagnostics group’s financiers stated the deal was too low offered a rise in need for the coronavirus screening devices that Qiagen makes. Based in Massachusetts, Thermo Fisher stated on...
CureVac BV said on Friday it raised $213.3 million in its initial public offering in New York, setting the stage for the first stock market debut of a company developing a potential vaccine to combat the coronavirus. The German biotechnology firm, backed by Microsoft...
According to Bloomberg, several big names in the Wall Street sports investment business came out with a plan to tackle racist abuse in Italian soccer while helping Serie A increase its value. In the last few months, at least four Private Equity firms – Advent...
Berkshire Partners, a Boston-based buyout firm, has started pitching its 10th midmarket fund, according to prospective investors and a regulatory filing. The firm is targeting $6.5 billion for Berkshire Fund X LP, people familiar with the fundraising told WSJ Pro...
Plant-based burger maker Impossible Foods said on Thursday it secured $200 million (153.03 million pounds) in funding, less than six months after it raised the largest investment ever for a food tech startup, bringing total funds raised since its founding in 2011 to... 